Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04690413 · ClinicalTrials.gov registry record · NA
NOWDx Test for the Detection of Antibodies to COVID-19
A NA study of COVID-19 and SARS-CoV-2, sponsored by NOWDiagnostics.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 3
- Study locations
NCT04690413 is a NA study of COVID-19 and SARS-CoV-2 that has completed, run by NOWDiagnostics. The registered enrollment target is 129 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT04690413, a NA study of COVID-19 and SARS-CoV-2, has completed, sponsored by NOWDiagnostics.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently marketed device. The NOWDx COVID-19 Test is an in vitro lateral flow immunoassay intended for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (venous and fingerstick).
Conditions Studied
Interventions
- DEVICE NOWDx COVID-19 Test
Study Locations (3)
Arizona
- Del Sol Research Management, LLC - Tucson
Florida
- Comprehensive Clinical Research, LLC - West Palm Beach
Tennessee
- Clinical Research Solutions, LLC - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04690413
The ClinicalTrials.gov registry entry for NCT04690413 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is NOWDiagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which NOWDx COVID-19 Test is the first listed.
NCT04690413 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, Florida, Tennessee.
Frequently Asked Questions
What is clinical trial NCT04690413 about?
NCT04690413 is a clinical study titled "NOWDx Test for the Detection of Antibodies to COVID-19". This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently marketed device. The NOWDx COVID-19 Test is an in vitro lateral flow immunoassay intended for qualitat...
What is the current status of trial NCT04690413?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2020-09-01. Estimated completion is 2020-12-31.
What conditions does trial NCT04690413 study?
This clinical trial studies the following conditions: COVID-19, SARS-CoV-2, Coronavirus.
What interventions are being tested in trial NCT04690413?
The interventions under investigation include: NOWDx COVID-19 Test (DEVICE).
Who is sponsoring clinical trial NCT04690413?
This trial is sponsored by NOWDiagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04690413 being conducted?
This trial has 3 study locations across Arizona, Florida, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.